cp 66713 has been researched along with adenosine-5'-(n-ethylcarboxamide) in 2 studies
| Studies (cp 66713) | Trials (cp 66713) | Recent Studies (post-2010) (cp 66713) | Studies (adenosine-5'-(n-ethylcarboxamide)) | Trials (adenosine-5'-(n-ethylcarboxamide)) | Recent Studies (post-2010) (adenosine-5'-(n-ethylcarboxamide)) |
|---|---|---|---|---|---|
| 22 | 0 | 4 | 1,333 | 4 | 133 |
| Protein | Taxonomy | cp 66713 (IC50) | adenosine-5'-(n-ethylcarboxamide) (IC50) |
|---|---|---|---|
| Adenosine receptor A3 | Homo sapiens (human) | 0.0097 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
| Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.4498 | |
| Adenosine receptor A2a | Homo sapiens (human) | 0.0336 | |
| Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.0175 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0007 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.0513 | |
| Adenosine receptor A1 | Gallus gallus (chicken) | 0.017 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobson, KA; van Galen, PJ; Williams, M | 1 |
| Browne, RG; Howard, HR; Koe, BK; Lebel, LA; Sarges, R; Seymour, PA | 1 |
1 review(s) available for cp 66713 and adenosine-5'-(n-ethylcarboxamide)
| Article | Year |
|---|---|
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
Topics: Adenosine; Animals; Humans; Models, Chemical; Receptors, Purinergic; Second Messenger Systems; Structure-Activity Relationship | 1992 |
1 other study(ies) available for cp 66713 and adenosine-5'-(n-ethylcarboxamide)
| Article | Year |
|---|---|
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antidepressive Agents; Behavior, Animal; Caffeine; Cats; Cell Membrane; Cerebral Cortex; Chemical Phenomena; Chemistry; Corpus Striatum; Male; Molecular Structure; Motor Activity; Purinergic Antagonists; Quinoxalines; Rats; Receptors, Purinergic; Sleep; Structure-Activity Relationship; Triazoles | 1990 |